Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,058,998 papers from all fields of science
Search
Sign In
Create Free Account
Bufexamac
Known as:
p-Butoxyphenylacethydroxamic Acid
, p Butoxyphenylacethydroxamic Acid
, Benzeneacetamide, 4-butoxy-N-hydroxy-
Expand
A benzeneacetamide with anti-inflammatory, analgesic, and antipyretic action. It is administered topically, orally, or rectally.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
11 relations
Broader (1)
Anti-Inflammatory Agents, Non-Steroidal
Narrower (3)
Bufexamac-ratiopharm
Droxaryl
Jomax
In Blood
agonists
analogs & derivatives
antagonists & inhibitors
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Eine heimtückische und häufige Nebenwirkung: Kontaktallergien durch das Ekzemtherapeutikum Bufexamac. Ergebnisse des IVDK
A. Schnuch
,
O. Gefeller
,
W. Uter
2005
Corpus ID: 71386312
Hintergrund: Bufexamac, ein bei Ekzemen wie der atopischen Dermatitis topisch eingesetztes Antiphlogistikum, hat…
Expand
2003
2003
Schwere allergische Kontaktdermatitis mit generalisierter Streuung auf Bufexamac unter dem Bild eines Baboon -Syndroms
S. Proske
,
W. Uter
,
A. Schnuch
,
W. Hartschuh
2003
Corpus ID: 71945914
HISTORY AND CLINICAL FINDINGS: A 48-year-old woman presented with acute, pruritic, sharply demarcated, erythematous…
Expand
2003
2003
[Severe allergic contact dermatitis with generalized spread due to bufexamac presenting as the "baboon" syndrome].
S. Proske
,
W. Uter
,
A. Schnuch
,
W. Hartschuh
Deutsche Medizinische Wochenschrift
2003
Corpus ID: 23992084
HISTORY AND CLINICAL FINDINGS A 48-year-old woman presented with acute, pruritic, sharply demarcated, erythematous…
Expand
1998
1998
Photo Koebner Phenomenon in Erythema-multiforme-Like Eruption Induced by Contact Dermatitis due to Bufexamac
Y. Kurumaji
Dermatology
1998
Corpus ID: 46827533
A photo Koebner phenomenon following contact dermatitis due to bufexamac is described. A 52-year-old man presented with…
Expand
1997
1997
Epidemiological significance of bufexamac as a frequent and relevant contact sensitizer
B. Kränke
,
C. Szolar-Platzer
,
P. Komericki
,
J. Dderhaschnig
,
Werner Aberer
Contact Dermatitis
1997
Corpus ID: 25995984
Bufexumae‐containing ointments and creams are widely used by many patients with eczematous disorders as an alternative to topical…
Expand
1989
1989
Contact allergy to bufexamac
Christian M. Perret
,
R. Happle
Contact Dermatitis
1989
Corpus ID: 8692981
3. Levy A, Hanau D, Foussereau J. Contact dermatitis in children. Contact Dermatitis 1980: 6: 260-262. 4. Veien N K, Ratte! T…
Expand
Highly Cited
1985
Highly Cited
1985
[Comparative testing of Kamillosan cream and steroidal (0.25% hydrocortisone, 0.75% fluocortin butyl ester) and non-steroidal (5% bufexamac) dermatologic agents in maintenance therapy of eczematous…
P. Aertgeerts
,
M. Albring
,
+4 authors
B. Weigl
H+G Zeitschrift für Hautkrankeheiten
1985
Corpus ID: 43893256
We report on 161 patients suffering from inflammatory dermatoses on hands, forearms, and lower legs who had been initially…
Expand
1977
1977
Efficacy of bufexamac (NFN) cream in skin diseases. A double-blind multicentre trial.
J. Christiansen
,
E. Gadborg
,
+9 authors
R. Wehnert
Dermatologica
1977
Corpus ID: 34757499
The effect of a new non-steroid anti-inflammatory substance (bufexamac) in a special constituent was compared with that of 0.1…
Expand
1975
1975
Contact sensitivity to bufexamac
J. Lachapelle
Contact Dermatitis
1975
Corpus ID: 32165463
Bufexamac (or parabutoxyphenylacethydroxamic acid) is an analgesic, anti-inflammatory and antipyretic drug, that is administered…
Expand
1973
1973
Contact allergy to bufexamac.
G. Smeenk
Dermatologica
1973
Corpus ID: 42323456
A 44-year-old woman developed an allergic contact eczema due to bufexamac (Droxaryl cream) after the use of this cream for a…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE